FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinomaTokuzo Arao, Masatoshi Kudo, Kazuomi Ueshima et al.|Hepatology|2012Cited by 154
Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort studyMasashi Okamoto, Yoichi Hiasa, Teruki Miyake et al.|PLoS ONE|2018Cited by 69
Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitisShogo Kitahata, Yoichi Hiasa, Yasunori Yamamoto et al.|Scientific Reports|2021Cited by 59
Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver diseaseTeruki Miyake, Yoichi Hiasa, Sakiko Yoshida et al.|Open Medicine|2018Cited by 48
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteriaHironori Ochi, Kouji Joko, Atsushi Hiraoka et al.|Journal of Gastroenterology|2020Cited by 45